Previously several studies reported recurrent mutations and loss in CDKN2A in many human cancer types such as pancreatic cancer and oral squamous cell carcinoma (Zhen et al., 2015; Padhi et al., 2017). This evidence concerns the gene CDKN2A and pancreatic neoplasm.